N Normanno Selected Research

N Normanno Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 04/2000
8	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 11/2012
7	Breast Neoplasms (Breast Cancer) 08/2012 - 01/2002
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 07/2010
6	Carcinoma (Carcinomatosis) 05/2005 - 03/2000
3	Circulating Neoplastic Cells 01/2021 - 04/2000
2	Neoplasm Metastasis (Metastasis) 03/2012 - 06/2005
2	Pain (Aches) 09/2010 - 06/2005
1	Disease Progression 01/2022
1	Cholangiocarcinoma 01/2021
1	Vulvar Neoplasms (Vulvar Cancer) 11/2020
1	Thyroid Neoplasms (Thyroid Cancer) 11/2020
1	Lung Neoplasms (Lung Cancer) 11/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2020
1	Overweight 08/2012
1	Hemorrhage 01/2012
1	Melanoma (Melanoma, Malignant) 09/2011
1	medullary Thyroid cancer 09/2010
1	Leiomyoma (Uterine Fibroids) 01/2007
1	Leiomyosarcoma 01/2007
1	Bone Diseases (Bone Disease) 06/2005

Drug/Important Bio-Agent (IBA)

13	ErbB Receptors (EGF Receptor)IBA 10/2023 - 04/2000
7	Cetuximab (Erbitux)FDA Link 01/2023 - 09/2014
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2011 - 03/2000
6	Proteins (Proteins, Gene)FDA Link 09/2011 - 03/2000
6	Epidermal Growth Factor (EGF)IBA 05/2005 - 03/2000
5	Peptides (Polypeptides)IBA 05/2005 - 03/2000
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2002
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 07/2010
3	Monoclonal AntibodiesIBA 09/2014 - 01/2002
3	Tyrosine Kinase InhibitorsIBA 07/2010 - 01/2002
3	LigandsIBA 07/2010 - 03/2003
3	Gefitinib (Iressa)FDA Link 10/2005 - 01/2002
3	Trastuzumab (Herceptin)FDA Link 10/2005 - 01/2002
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 01/2016
2	Circulating Tumor DNAIBA 01/2023 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	Zoledronic Acid (Zometa)FDA Link 08/2012 - 03/2012
2	Messenger RNA (mRNA)IBA 09/2011 - 04/2000
2	Docetaxel (Taxotere)FDA Link 09/2010 - 05/2006
2	Phosphotransferases (Kinase)IBA 09/2010 - 05/2005
2	Tyrosine (L-Tyrosine)FDA Link 09/2010 - 05/2005
2	Transforming Growth Factor alpha (TGF-alpha)IBA 11/2000 - 03/2000
2	AmphiregulinIBA 11/2000 - 03/2000
1	avelumabIBA 01/2023
1	ivosidenibIBA 01/2022
1	infigratinibIBA 01/2022
1	pemigatinibIBA 01/2022
1	CytokinesIBA 11/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	pembrolizumabIBA 11/2020
1	AntibodiesIBA 11/2020
1	Leucovorin (Folinic Acid)FDA Link 01/2016
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2016
1	Fluorouracil (Carac)FDA LinkGeneric 01/2016
1	Growth Factor ReceptorsIBA 09/2014
1	Formaldehyde (Formol)FDA Link 11/2012
1	Letrozole (Femara)FDA LinkGeneric 08/2012
1	Hormones (Hormone)IBA 08/2012
1	AcidsIBA 08/2012
1	Triptorelin Pamoate (Trelstar)FDA Link 08/2012
1	Tamoxifen FDA LinkGeneric 08/2012
1	Conditioned Culture MediaIBA 03/2012
1	Estrogen ReceptorsIBA 03/2012
1	Bevacizumab (Avastin)FDA Link 01/2012
1	saracatinibIBA 09/2011
1	4- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA 09/2011
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2010
1	Pemetrexed (MTA)FDA Link 09/2010
1	vandetanib (ZD6474)IBA 09/2010
1	Glycogen Synthase Kinase 3 betaIBA 01/2007
1	beta CateninIBA 01/2007
1	AnthracyclinesIBA 05/2006
1	Epirubicin (Ellence)FDA LinkGeneric 05/2006
1	Taxoids (Taxanes)IBA 05/2006
1	OligonucleotidesIBA 11/2000
1	Keratin-19 (Keratin 19)IBA 04/2000
1	Carcinoembryonic AntigenIBA 04/2000
1	Antisense OligonucleotidesIBA 03/2000
1	Cisplatin (Platino)FDA LinkGeneric 03/2000
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2000
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2000

Therapy/Procedure

6	Therapeutics 01/2023 - 05/2006
4	Precision Medicine 01/2022 - 01/2018
4	Drug Therapy (Chemotherapy) 01/2021 - 05/2006
2	Investigational Therapies (Experimental Therapy) 11/2000 - 03/2000
1	Immunotherapy 11/2021
1	Neoadjuvant Therapy 05/2006
1	Aftercare (After-Treatment) 03/2000